Media Relations Media Releases Children’s nutrition influenced by local neighbourhoods June 21, 2016 Imaging study shows promising results for patients with schizophrenia May 27, 2016 Technology delivers personalized treatment to patients with tremors May 19, 2016 Eupraxia announces first patient dosed in phase I clinical trial of EP-104IAR to treat osteoarthritis-related pain May 17, 2016 London researchers first in Canada to use improved prostate cancer imaging May 9, 2016 First Canadian study demonstrates potential to remove patients from active liver transplant list after curing hepatitis C May 3, 2016 Celebrating research excellence and innovation April 13, 2016 Surgeries take 22 per cent longer in teaching hospitals: Ontario study March 30, 2016 London Health Research Day showcases ground-breaking research in London March 24, 2016 Local scientist will use eHealth technology to improve in-home dialysis March 7, 2016 First Page Icon Created with Sketch. First page « First Previous Page Icon Created with Sketch. Previous page ‹ Previous Elipsis Icon Created with Sketch. … Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Next Page Icon Created with Sketch. Next page Next › Last Page Icon Created with Sketch. Last page Last » 2023 Media Releases 2022 Media Releases 2021 Media Releases 2020 Media Releases 2019 Media Releases 2018 Media Releases 2017 Media Releases 2016 Media Releases
Eupraxia announces first patient dosed in phase I clinical trial of EP-104IAR to treat osteoarthritis-related pain May 17, 2016
First Canadian study demonstrates potential to remove patients from active liver transplant list after curing hepatitis C May 3, 2016
October 4, 2024 Almost half of persons who inject drugs (PWID) with endocarditis will die within five years; women are disproportionately affected